Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1

Status

Terminated 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 3

Conditions

Opioid-Induced Constipation 3Constipation 3

Interventions

tegaserod 3naloxegol 3Radiotherapy 3Cisplatin 3Surveys and Questionnaires 2Radiation 2Lidocaine 2prucalopride 1pegfilgrastim 1oxycodone naloxone combination 1indole-3-carbinol 1hydrated silica gel-based toothpaste 1glucarpidase 1angiotensin I (1-7) 1alvimopan 1aluminum hydroxide, magnesium hydroxide, drug combination 1Vitamin D 1Transcutaneous Electric Nerve Stimulation 1Thyrotropin-Releasing Hormone 1Tablets 1Surgical Procedures, Operative 1Sennosides 1Selenomethionine 1Phenolphthalein 1Observation 1Nutrition Assessment 1Neck Dissection 1Methotrexate 1Methods 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × tegaserod × Other × Clear all
NCT00399659 2012-05-01

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Novartis

Phase 3 Terminated
360 enrolled
Other

Opioid-Induced Constipation, Constipation

NCT00365820 2012-04-20

Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

Novartis

Phase 2/3 Terminated
670 enrolled
Other

Opioid-Induced Constipation, Constipation

NCT00414024 2012-04-20

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Novartis

Phase 3 Terminated
11 enrolled
Other

Opioid-Induced Constipation, Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡